Name: Adapting 3 Rapid Amplification of CDNA Ends to Map Transcripts in Cancer (Video) | JoVE Journal
Uploaded: 2018-03-28T15:00:00.000+00:00
Duration: 9 min 38 s
Description: Learn 3' RACE protocols using different DNA polymerases to map mRNA sequences from cancer cell lines. This method identifies open reading frames, stop codons, and 3' UTRs for transcript analysis.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

playerTrialDesktop

We would like to acknowledge Bettine Gibbs for her technical help.

Wear a lab coat, gloves, and safety glasses at all times while performing all procedures in this protocol. Ensure that containers/tubes containing the phenol and guanidine isothiocyanate reagent are only opened in a certified hood, and dispose of phenol waste in a designated container. Use DNAse/RNAse-free sterile tubes, tips, and reagents.
1. Cell Culture
<ol>
	<li>Grow the HeLa cell line and two suspension mantle cell lymphoma cell lines, Granta-519 and Jeko-1, in DMEM containing 10% FBS and 100 U/mL Penicillin/Streptomycin in a humidified incubator with 5% CO2 at 37 &#176;C. Dilute the cells 1:10 and count using a particle counter14.</li>
	<li>For RNA extraction, plate 500,000 cells/well in a 6 well plate (2 mL media per well). After incubation for 24 h, collect RNA from the cells.</li>
</ol>
2. RNA Extraction
<ol>
	<li>Harvesting cells 
	NOTE: With the exception of the centrifugation step, perform all the listed steps in a tissue culture hood to maintain sterility.
	<ol>
		<li>For suspension cells (Jeko-1 and Granta-519):
		<ol>
			<li>Transfer the cells (together with 2 mL of media) to a 15 mL tube, and centrifuge at 1,725 x g for 5 min. Aspirate the media and leave the cell pellet in the bottom of the tube.</li>
			<li>Resuspend the cell pellet in 50 &#181;L of 1x Phosphate Buffered Saline (PBS). Add 500 &#181;L of monophasic phenol and guanidine isothiocyanate reagent to each sample in the 1.5 mL microcentrifuge tube. Mix well and leave at room temperature (RT) for 5 min while inverting the microcentrifuge tube every 1 min.</li>
		</ol>
		</li>
		<li>For adherent cells (HeLa):
		<ol>
			<li>Aspirate the cell culture media from each well. Add 1 mL of PBS to each well to wash off debris.</li>
			<li>Remove the PBS and add 500 &#181;L of monophasic phenol and guanidine isothiocyanate reagent to each well.</li>
			<li>Incubate at RT for 5 min with gentle rocking. Transfer to a 1.5 mL microcentrifuge tube.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Cell lysis
	<ol>
		<li>Freeze the phenol and guanidine isothiocyanate cell mixture at -20 &#176;C for 1 h. 
		NOTE: The mix can be left at -20 &#176;C overnight or until needed.</li>
		<li>Thaw the phenol and guanidine isothiocyanate cell mixture on ice. Add 100 &#181;L of chloroform to the microcentrifuge tube in a PCR hood. Vortex the sample for 10 - 15 s until the mixture is pink and opaque. Incubate the sample on ice (at 4 &#176;C) for 15 min.</li>
		<li>Centrifuge the sample for 15 min at 20,800 x g and 4 &#176;C. Carefully remove the upper colorless aqueous phase (~ 200 &#181;L) and transfer to a new 1.5 mL microcentrifuge tube.</li>
	</ol>
	</li>
	<li>RNA precipitation
	<ol>
		<li>Add an equal volume of isopropanol to each sample. Add 1 &#181;L of coprecipitant (see Table of Materials) to each sample to act as a carrier for the RNA and help visualize the RNA in subsequent steps. Incubate the sample at -80 &#176;C for at least 4 h. For best results, incubate overnight at -80 &#176;C.</li>
		<li>Transfer the sample to a cooled centrifuge. Centrifuge for 35 min at 20,800 x g / 4 &#176;C; the RNA will appear as a blue speck on the bottom of the tube. Carefully remove the isopropanol from the sample. Add 500 &#181;L of 80% ethanol and resuspend the pellet by briefly vortexing for 3 s.</li>
		<li>Centrifuge the sample at 20,800 x g at RT for 5 min. Remove all the ethanol from the sample. Let the sample air-dry for about 10 min. Resuspend the sample in 35 &#181;L of RNAse-free water. Place on a heat block (65 &#176;C) for 5 min to ensure that the RNA is fully in solution, and immediately place the tube on ice.</li>
		<li>Determine the concentration of total RNA using a spectrophotometer as previously described, except use 1.5 &#181;L of the RNA sample instead of 1 &#181;L15. Optionally, run 1 &#181;g of total RNA on a 1% agarose gel to determine the RNA integrity.</li>
	</ol>
	</li>
</ol>
3. DNase Treatment
<ol>
	<li>After quantification of the RNA, perform DNAse treatment on the total RNA to degrade any genomic DNA. For each sample, add the following reagents from the RNAse-free DNAse kit to make a 20 &#181;L total reaction mix in a separate microcentrifuge tube:
	<ol>
		<li>Mix 2 &#181;L of DNase 10X reaction buffer with 4.4 &#181;g of total RNA. Bring to a total of 14 &#181;L with water.</li>
		<li>Add 2 &#181;L of RNase-free DNAse. Incubate at 37 &#176;C for 30 min in the presence of 2 &#181;L of RNase inhibitor (from the Reverse Transcription Kit).</li>
		<li>Add 2 &#181;L of Stop Solution and heat on a heat block for 10 min at 70 &#176;C to inactivate the DNAse enzyme. 
		NOTE: DNAse treatment is optional.</li>
	</ol>
	</li>
</ol>
4. cDNA Synthesis
For a final reaction volume of 50 &#181;L:
<ol>
	<li>For a final reaction volume of 50 &#181;L: Transfer 22 &#181;L of the DNase treated RNA to a new tube, or transfer 4 &#181;g of total RNA with added water to a total volume of 22 &#181;L to a new tube. Add 2 &#181;L of the T7 oligo dT25 primer from 10 &#181;M primer solution. The sequence for the T7 oligo dT25 primer is 5&#39;-GCCGGTAATACGACTCACTATAGTTTTTTTTTTTTTTTTTTTTTTTTT-3&#39;.</li>
	<li>From the Reverse Transcription kit add 2 &#181;L of the RNase inhibitor (20 U/&#181;L), 8 &#181;L of the 5x&#160;Reaction buffer, 4 &#181;L of 10 mM dNTPs, and 2 &#181;L of the Reverse transcriptase (200 U/&#181;L). 
	NOTE: Set up a reaction without reverse transcriptase to act as a negative control.</li>
	<li>Incubate at 42 &#176;C for 1 h. Transfer directly to ice. Heat the tube at 75 &#176;C for 5 min and place the tube on ice.</li>
</ol>
5. Primer Search for Fusion Gene Transcript
<ol>
	<li>Primer design
	<ol>
		<li>Download the cDNA sequence from the Ensemble genome browser (ENST00000360839.6/NM_017747), and identify a region within the ORF of the target transcript (ANKHD1) upstream of the stop codon. Copy and paste the entire region (up to 700 nucleotides) containing sequences upstream of the stop codon into the sequence entry region of the primer design software (&#60;https://www.idtdna.com/Primerquest/Home/Index&#62;).</li>
		<li>Select the show custom design option and select 10 for the number of primers that the system should generate (results to return) and leave all the other parameters set to default.</li>
		<li>Choose five forward primers and two reverse primers that do not overlap. Order primers and reconstitute with RNAse/DNAse-free water to a final concentration of 10 &#181;M. More details about general primer design for PCR are covered elsewhere16.</li>
	</ol>
	</li>
	<li>PCR to identify potential primers for use in subsequent 3&#39; RACE 
	NOTE: To determine the final forward primers to use in the reaction, test the designed primers by setting up different combinations of forward and reverse primers for regular PCR in a PCR hood.
	<ol>
		<li>Transfer the cDNA (2 &#181;L) to a fresh 0.5 mL PCR tube. Add 1 &#181;L of the forward primer and 1 &#181;L of the reverse primer (from a 10 mM primer solution). Make up to 12.5 &#181;L by adding 8.5 &#181;L of nuclease-free water. Add 12.5 &#181;L of the 2x PCR-to-Gel Master Mix.</li>
		<li>Use the following PCR thermal cycling conditions: 95 &#176;C for 2 min followed by 29 cycles of 95 &#176;C for 30 s, 60 &#176;C for 30 s, and 72 &#176;C for 1 min. Set the final cycle at 68 &#176;C for 7 min.</li>
		<li>After the PCR, run the products on a 1% agarose gel stained with ethidium bromide. Details of electrophoresis are as previously described with a few modifications17.
		<ol>
			<li>Dissolve 1 g of agarose in 100 mL of Tris-Acetate (TAE) buffer in a 250 mL flask. Boil in a microwave.</li>
			<li>Leave to cool for 1 min and add 7.5 &#181;L of ethidium bromide solution (10 mg/mL stock) in a fume hood. Mix well by swirling the flask and pour into a horizontal gel apparatus. Leave at RT in the fume hood for at least 30 min to allow the gel to solidify.</li>
			<li>Cover the gel with 1x&#160;TAE buffer and load 10 &#181;L of the PCR product onto the agarose gel together with 3 - 5 &#181;L of the DNA molecular weight ladder. Run at 175 V for 10 min. Visualize the products using an imager, and if further separation of products is needed, run the gel for an additional 5 - 10 min.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Selection of nested primers for 3&#39; RACE
	<ol>
		<li>Analyze the results of the PCR agarose gel to select primers that have a distinct, strong, single PCR band. Use the 5&#39;-most primer (ANKHD15&#39;-CCTTCCCAGCGAGTTTCTAC-3&#39;) together with the T7 oligodT25 primer in the first PCR run.</li>
		<li>Select the nested primer that is located downstream of the first primer (ANKHD1 5&#39;-CGTTGGACACAGTGGAATCT-3&#39;), and use it with the T7 primer (5&#39;-GGCCTAATACGACTCACTATAG-3&#39;) in the second set of the PCR reactions.</li>
	</ol>
	</li>
</ol>
6. Optimizing 3&#39; RACE to Map the 3&#39; UTR Using Two Different Enzymes
NOTE: There has been an increase in the diversity of DNA polymerases used for PCR; therefore, we wanted to determine standard conditions that can be applied even when using different enzymes for 3&#39; RACE PCR reactions. The reverse primers for any transcript are kept constant; the only changes are in the nested forward primers that are specific for the target transcript.
<ol>
	<li>Protocol 1: 3&#39; RACE using a modified DNA polymerase from Pyrococcus furiosus (Pfu)
	<ol>
		<li>First PCR
		<ol>
			<li>Transfer 1 &#181;L of cDNA to a PCR tube and add 5 &#181;L of 10x&#160;Pfu reaction buffer. Add 1 &#181;L of the first nested forward primer, 1 &#181;L of the T7 oligodT25 primer, and 1 &#181;L of dNTPs (from a 10 mM solution).</li>
			<li>Make up to 49 &#181;L total volume by adding 40 &#181;L of water. Add 1 &#181;L of Pfu DNA polymerase and mix well. Run the PCR using the PCR profile in Table 1.</li>
		</ol>
		</li>
		<li>Second PCR
		<ol>
			<li>Transfer 2 &#181;L of the products from the first PCR to a new PCR tube and mix with 5 &#181;L of 10x&#160;PfuUltra II reaction buffer. Add 1 &#181;L of the second nested PCR primer, 1 &#181;L of the T7 primer, and 1 &#181;L of dNTPs (10 mM solution).</li>
			<li>Make up to 49 &#181;L total reaction volume by adding 39 &#181;L of water. Add 1 &#181;L of Pfu DNA polymerase. Run the PCR using the same PCR profile as the first PCR setup (Table 1).</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Protocol 2: 3&#39; RACE using a chimeric DNA polymerase consisting of a DNA binding domain fused to a Pyrococcus-like proofreading polymerase PCR master mix
	<ol>
		<li>First PCR
		<ol>
			<li>Transfer 1 &#181;L of cDNA to a PCR tube. Add 1 &#181;L of the first nested forward primer and 1 &#181;L of the T7 oligodT25 primer. Make up to 25 &#181;L by adding 22 &#181;L of water.</li>
			<li>Add 25 &#181;L of 2x&#160;PCR Master Mix and mix well. Use the PCR cycling conditions described in Table 2.</li>
		</ol>
		</li>
		<li>Second PCR
		<ol>
			<li>Transfer 2 &#181;L of the products from the first PCR to a new PCR tube. Add 1 &#181;L of the second nested PCR primer together with 1 &#181;L of the T7 reverse primer.</li>
			<li>Make up to 25 &#181;L by adding 22 &#181;L of water. Add 25 &#181;L of 2X PCR Master Mix. Run the PCR using the same PCR profile as the first PCR setup (Table 2).</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>
7. Verify the second PCR product of 3&#39; RACE.
<ol>
	<li>Take 5 - 10 &#181;L of the second PCR product (as well as product from the first round of PCRs if the transcript is abundantly expressed) and run on an agarose gel. Set up the gel and run the electrophoresis as previously described (steps 5.2.3.1 to 5.2.3.3). Visualize results on an imager.</li>
</ol>
8. Product Purification and Sequencing
<ol>
	<li>Purify the gel PCR products from the second PCR using the Gel and PCR Fragment DNA Clean-Up System as per the manufacturer&#39;s protocol.</li>
	<li>Perform Sanger sequencing (alternatively, send the gel purified PCR product samples and appropriate sequencing primers to a sequencing lab). Analyze the sequencing data after Sanger sequencing.</li>
	<li>Download sequence-analyzing software (see Table of Materials) and import the trace files into the software. Use the individual PURE Base QVs (Quality Values) to obtain the Base call information18. Download the chromatogram with high quality traces for viewing. 
	Optional: The gel purified product can be cloned using an appropriate cloning kit and the isolated clones sent for Sanger sequencing.</li>
</ol>

<ol><li>Mandel, C., Bai, Y., Tong, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Protein+factors+in+pre-mRNA+3%27-end+processing%5BTitle%5D)+AND+%22Cell+Mol+Life+Sci%22%5BJournal%5D)">Protein factors in pre-mRNA 3'-end processing.</a> Cell Mol Life Sci. 65 (7-8), 1099-1122 (2008).</li>
<li>Danckwardt, S., Hentze, M., Kulozik, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((3%27+end+mRNA+processing%3A+Molecular+mechanisms+and+implications+for+health+and+disease%5BTitle%5D)+AND+%22EMBO+J%22%5BJournal%5D)">3' end mRNA processing: Molecular mechanisms and implications for health and disease.</a> EMBO J. 27 (3), 482-498 (2008).</li>
<li>Derti, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+quantitative+atlas+of+polyadenylation+in+five+mammals%5BTitle%5D)+AND+%22Genome+Res%22%5BJournal%5D)">A quantitative atlas of polyadenylation in five mammals.</a> Genome Res. 22 (6), 1173-1183 (2012).</li>
<li>Sambrook, J., Russell, D. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rapid+amplification+of+3%E2%80%B2+cDNA+ends+%283%E2%80%B2-RACE%29%5BTitle%5D)+AND+%22Cold+Spring+Harb+Protoc%22%5BJournal%5D)">Rapid amplification of 3′ cDNA ends (3′-RACE).</a> Cold Spring Harb Protoc. 2006 (1), (2006).</li>
<li>Masamha, C. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((CFIm25+regulates+glutaminase+alternative+terminal+exon+definition+to+modulate+miR-23+function%5BTitle%5D)+AND+%22RNA%22%5BJournal%5D)">CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.</a> RNA. 22 (6), 830-838 (2016).</li>
<li>Rodu, B. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0002962915361474">Molecular Biology in Medicine: The polymerase chain reaction: the revolution within.</a> Am J Med Sci. 299 (3), 210-216 (1990).</li>
<li>Bertioli, D. Rapid amplification of cDNA ends. <a target="_blank" href="https://link.springer.com/protocol/10.1385/0-89603-483-6:233">PCR Cloning Protocols: Methods in Molecular Biology</a>. White, B. A. 67, Humana Press. 233-238 (1997).</li>
<li>Freeman, L. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cloning+full-length+transcripts+and+transcript+variants+using+5%27+and+3%27+RACE%5BTitle%5D)+AND+%22Lipoproteins+and+Cardiovascular+Disease%3A+Methods+in+Molecular+Biology+%28Methods+and+Protocols%29%22%5BJournal%5D)">Cloning full-length transcripts and transcript variants using 5' and 3' RACE.</a> Lipoproteins and Cardiovascular Disease: Methods in Molecular Biology (Methods and Protocols). Freeman, L. 1027, Humana Press. 3-17 (2013).</li>
<li>Masamha, C. P., Albrecht, T. R., Wagner, E. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Discovery+and+characterization+of+a+novel+CCND1%2FMRCK+gene+fusion+in+mantle+cell+lymphoma%5BTitle%5D)+AND+%22J+Hematol+Oncol%22%5BJournal%5D)">Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.</a> J Hematol Oncol. 9 (1), 1-5 (2016).</li>
<li>Parker, B. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+tumorigenic+FGFR3-TACC3+gene+fusion+escapes+miR-99a+regulation+in+glioblastoma%5BTitle%5D)+AND+%22J+Clin+Investig%22%5BJournal%5D)">The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.</a> J Clin Investig. 123 (2), 855-865 (2013).</li>
<li>Prakash, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Expression+of+conjoined+genes%3A+Another+mechanism+for+gene+regulation+in+eukaryotes%5BTitle%5D)+AND+%22PLOS+ONE%22%5BJournal%5D)">Expression of conjoined genes: Another mechanism for gene regulation in eukaryotes.</a> PLOS ONE. 5 (10), e13284(2010).</li>
<li>Mertens, F., Johansson, B., Fioretos, T., Mitelman, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+emerging+complexity+of+gene+fusions+in+cancer%5BTitle%5D)+AND+%22Nat+Rev+Cancer%22%5BJournal%5D)">The emerging complexity of gene fusions in cancer.</a> Nat Rev Cancer. 15 (6), 371-381 (2015).</li>
<li>Mayr, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Evolution+and+biological+roles+of+alternative+3%27UTRs%5BTitle%5D)+AND+%22Trends+Cell+Biol%22%5BJournal%5D)">Evolution and biological roles of alternative 3'UTRs.</a> Trends Cell Biol. 26 (3), 227-237 (2016).</li>
<li>International Committee For Standardization In, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Protocol+for+evaluation+of+automated+blood+cell+counters%5BTitle%5D)+AND+%22Clin+Lab+Haematol%22%5BJournal%5D)">Protocol for evaluation of automated blood cell counters.</a> Clin Lab Haematol. 6 (1), 69-84 (1984).</li>
<li>Desjardins, P., Conklin, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((NanoDrop+microvolume+quantitation+of+nucleic+acids%5BTitle%5D)+AND+%22J+Vis+Exp%22%5BJournal%5D)">NanoDrop microvolume quantitation of nucleic acids.</a> J Vis Exp. (45), e2565(2010).</li>
<li>Lorenz, T. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Polymerase+chain+reaction%3A+Basic+protocol+plus+troubleshooting+and+optimization+strategies%5BTitle%5D)+AND+%22J+Vis+Exp%22%5BJournal%5D)">Polymerase chain reaction: Basic protocol plus troubleshooting and optimization strategies.</a> J Vis Exp. (63), e3998(2012).</li>
<li>Lee, P. Y., Costumbrado, J., Hsu, C. -Y., Kim, Y. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Agarose+gel+electrophoresis+for+the+separation+of+DNA+fragments%5BTitle%5D)+AND+%22J+Vis+Exp%22%5BJournal%5D)">Agarose gel electrophoresis for the separation of DNA fragments.</a> J Vis Exp. (62), e3923(2012).</li>
<li>Curtis, P. C., Thomas, J. L., Phillips, N. R., Roby, R. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Optimization+of+primer+specific+filter+metrics+for+the+assessment+of+mitochondrial+DNA+sequence+data%5BTitle%5D)+AND+%22Mitochondrial+DNA%22%5BJournal%5D)">Optimization of primer specific filter metrics for the assessment of mitochondrial DNA sequence data.</a> Mitochondrial DNA. 21 (6), 191-197 (2010).</li>
<li>Letowski, J., Brousseau, R., Masson, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Designing+better+probes%3A+Effect+of+probe+size%2C+mismatch+position+and+number+on+hybridization+in+DNA+oligonucleotide+microarrays%5BTitle%5D)+AND+%22J+Microbiol+Methods%22%5BJournal%5D)">Designing better probes: Effect of probe size, mismatch position and number on hybridization in DNA oligonucleotide microarrays.</a> J Microbiol Methods. 57 (2), 269-278 (2004).</li>
<li>Lefever, S., Pattyn, F., Hellemans, J., Vandesompele, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Single-nucleotide+polymorphisms+and+other+mismatches+reduce+performance+of+quantitative+PCR+assays%5BTitle%5D)+AND+%22Clin+Chem%22%5BJournal%5D)">Single-nucleotide polymorphisms and other mismatches reduce performance of quantitative PCR assays.</a> Clin Chem. 59 (10), 1470-1480 (2013).</li>
<li>Singh, V. K., Govindarajan, R., Naik, S., Kumar, A. <a target="_blank" href="https://pdfs.semanticscholar.org/365f/f55d5d1ca2c64665cf11eaf1a856dc464a19.pdf">The effect of hairpin structure on PCR amplification efficiency.</a> Mol Biol Today. 1, 67-69 (2000).</li>
<li>Kalle, E., Kubista, M., Rensing, C. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27896140">Multi-template polymerase chain reaction.</a> Biomol Detect Quant. 2, 11-29 (2014).</li>
<li>Stransky, N., Cerami, E., Schalm, S., Kim, J. L., Lengauer, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+landscape+of+kinase+fusions+in+cancer%5BTitle%5D)+AND+%22Nat+Commun%22%5BJournal%5D)">The landscape of kinase fusions in cancer.</a> Nat Commun. 5, 4846(2014).</li>
</ol>

The authors have nothing to disclose.

Despite the advent of massive parallel sequencing technologies, on a gene-by-gene basis, 3&#39; RACE still remains the easiest and most economical method to identify the PAS and nucleotides adjacent to the poly(A) tail. The adaptation described here expands using 3&#39; RACE to both amplify and map sequences that include a portion of the ORF, the stop codon, and the entire 3&#39; UTR of the ANKHD1 mRNA transcript. A major advantage of 3&#39; RACE is that with a few minor adaptations, products from 3&#39; RACE ca...

The formation of the 3&#39; end is a critical step in mRNA maturation that comprises the cleavage of the pre-mRNA downstream of a PAS followed by the addition of ~250 untemplated adenines, which make up the poly(A) tail1,2. The poly(A) binding protein (PABP) binds to the poly(A) tail, and this protects the mRNA transcript from degradation, and facilitates translation1.
Current estimates suggest that 70% of human genes have multiple PASs, and thus undergo alternative polyadenylation, resulting in multiple 3&#39; ends3. Thus, it is important to identify where the poly(A) tail attaches to the rest of the 3&#39; UTR, as well as identify the PAS used by any given transcript. The advent of next-generation sequencing has resulted in the simultaneous identification of the 3&#39; UTRs and the PASs of thousands of genes. This increase in sequencing capability has required the development of bioinformatic algorithms to analyze data involving alternative polyadenylation of the 3&#39; end. For the de novo detection or validation of the PAS and hence mapping of the 3&#39; end of individual genes from large scale sequencing data, 3&#39; RACE remains the method of choice4,5. The sequences included in cDNA products of 3&#39; RACE normally include only a portion of the 3&#39; UTR that contains the poly(A) tail, the cleavage site, the PAS, and the sequences upstream of the PAS. Unlike PCR, which requires the design and use of gene specific forward and reverse primers, 3&#39; RACE only requires two gene specific nested forward primers. Hence, PCR requires a more detailed knowledge of the nucleotide sequence of a large region of the gene being amplified4,6. Since 3&#39; RACE uses the same reverse primer that targets the poly(A) tail for all polyadenylated RNA transcripts, only the forward primers need to be gene specific, thus, only requiring knowledge of a significantly smaller region of the mRNA. This enables the amplification of regions whose sequences are not fully characterized4,7. This has allowed 3&#39; RACE to be used not only to determine the 3&#39; end of a gene, but to also determine and characterize large regions upstream of the PAS that form a significant portion of the 3&#39; UTR. By combining 5&#39; RACE with the modified 3&#39; RACE that includes larger portions of the 3&#39; UTR and flanking regions, it is possible to fully sequence or clone an entire mRNA transcript from the 5&#39; end to its 3&#39; end8.
An example of this application of modified 3&#39; RACE is the recent identification of a novel CCND1-MRCK fusion gene transcript from Mantle Cell Lymphoma cell lines and cancer patients. The 3&#39; UTR consisted of sequences from both the CCND1 and MRCK genes and was recalcitrant to miRNA regulation9. The two nested CCND1 specific forward primers were complementary to the region immediately adjacent and downstream of the CCND1 stop codon. Although whole transcriptome sequencing together with specific bioinformatic tools can be used to detect gene fusions within the 3&#39; UTR10, many labs may lack the financial resources or bioinformatic expertise to make use of this technology. Hence, 3&#39; RACE is an alternative for de novo identification and validation of novel fusion genes involving the 3&#39; UTR. Considering the drastic increase in the number of reported fusion genes as well as read through transcripts, 3&#39; RACE has become a powerful tool in characterizing gene sequences11,12. In addition, recent studies have shown that different sequences within the 3&#39; UTR as well as the length of the 3&#39; UTR can affect mRNA transcript stability, localization, translatability, and function13. Due in part to an increased interest in mapping the transcriptome, there has been an increase in the number of different DNA polymerases being developed for use in the lab. It is important to determine what types of modifications can be made to the 3&#39; RACE protocol in order to utilize the available repertoire of DNA polymerases.
This work reports adapting 3&#39; RACE to map the entire 3&#39; UTR, the PAS, and the 3&#39; end cleavage site of the ANKHD1 transcript by using nested primers within the ANKHD1 section of the transcript and&#160;two different DNA polymerases.

<table><tbody><tr><td>HeLa cells</td><td>ATCC</td><td>CCL-2</td><td>Cervical cancer cell line.</td></tr><tr><td>Jeko-1 cells</td><td>ATCC</td><td>CRL-3006</td><td>Mantle cell lymphoma cell line.</td></tr><tr><td>Granta-519 cells</td><td>DSMZ</td><td>ACC-342</td><td>Mantle cell lymphoma cell line.</td></tr><tr><td>Fetal Bovine Serum</td><td>Sigma Aldrich</td><td>F6178</td><td>Fetal bovine serum for cell culture.</td></tr><tr><td>Penicillin/Streptomycin</td><td>ThermoFisherScientific</td><td>15140122</td><td>Antibiotic and antimycotic.</td></tr><tr><td>GlycoBlue</td><td>Ambion</td><td>AM9545</td><td>Coprecipitant.</td></tr><tr><td>DMEM</td><td>ThermoFisherScientific</td><td>10569044</td><td>Gibco brand cell culture media with GlutaMAX.</td></tr><tr><td>Nuclease Free-Water</td><td>ThermoFisherScientific</td><td>AM9938</td><td>Ambion DNase and RNAse free water(non DEPC treated).</td></tr><tr><td>Dulbecco&amp;rsquo;s Phosphate-Buffered Solution</td><td>Corning</td><td>21-030</td><td>1X PBS.</td></tr><tr><td>Chloroform</td><td>Sigma&amp;nbsp; Aldrich</td><td>C7559-5VL</td><td></td></tr><tr><td>2-propanol</td><td>Sigma Aldrich</td><td>I9516</td><td></td></tr><tr><td>Reagent Alcohol</td><td>Sigma Aldrich</td><td>793175</td><td>Ethanol</td></tr><tr><td>Ethidium Bromide solution</td><td>Sigma Aldrich</td><td>E1510</td><td></td></tr><tr><td>TRIzol Reagent</td><td>ThermoFisherScientific</td><td>15596026</td><td>Monophasic phenol and guanidine isothiocyanate reagent.</td></tr><tr><td>2X Extender PCR-to-Gel Master Mix</td><td>Amresco</td><td>N867</td><td>2X PCR-to-Gel Master Mix&amp;nbsp; containing loading dye used in routine quick PCR assays and primer search.</td></tr><tr><td>10mM dNTP</td><td>Amresco</td><td>N557</td><td></td></tr><tr><td>RQ1 RNase-Free DNase</td><td>Promega</td><td>M6101</td><td>Dnase treatment kit.</td></tr><tr><td>Gel Loading Dye Orange (6X)</td><td>New England BioLabs</td><td>B7022S</td><td></td></tr><tr><td>2X Phusion High-Fidelity PCR Master Mix with HF buffer</td><td>ThermoFisherScientific</td><td>F531S</td><td>2X PCR MasterMix containing a chimeric DNA polymerase consisting of a DNA binding domain fused to a Pyrococcus-like proofreading polymerase and other reagents.</td></tr><tr><td>PfuUltra II Fusion HS DNA polymerase</td><td>Agilent Technologies</td><td>600670</td><td>Modified DNA Polymerase from Pyrococcus furiosus (Pfu).</td></tr><tr><td>RevertAid RT Reverse Transcription Kit</td><td>Thermo Fischer</td><td>K1691</td><td>Used for&amp;nbsp; reverse transcription of mRNA into&amp;nbsp; cDNA synthesis. Kit includes&amp;nbsp; Ribolock RNAse inhibitor, RevertAid M-MuLV reverse transcriptase and other reagents listed in manuscript.</td></tr><tr><td>Pefect size 1Kb ladder</td><td>5 Prime</td><td>2500360</td><td>Molecular weight DNA ladder.</td></tr><tr><td>Alpha Innotech FluorChem Q MultiImage III</td><td>Alpha Innotech</td><td></td><td>Used to visualise ethidium bromide stained agarose gel.</td></tr><tr><td>Low Molecular Weight Ladder</td><td>New England BioLabs</td><td>N3233L</td><td>Molecular weight DNA ladder.</td></tr><tr><td>Vortex Mixer</td><td>MidSci</td><td>VM-3200</td><td></td></tr><tr><td>Mini Centrifuge</td><td>MidSci</td><td>C1008-R</td><td></td></tr><tr><td>Dry Bath</td><td>MidSci</td><td>DB-D1</td><td></td></tr><tr><td>NanoDrop 2000C</td><td>ThermoFisherScientific</td><td>ND-2000C</td><td>Spectrophotometer.</td></tr><tr><td>Wide Mini-Sub&amp;nbsp;Cell GT Horizontal Electrophoresis System</td><td>BioRad</td><td>1704469</td><td>Electrophoresis equipment-apparatus to set up gel</td></tr><tr><td>PowerPac Basic Power Supply</td><td>BioRad</td><td>1645050</td><td>Power supply for gel electrophoresis.</td></tr><tr><td>Agarose</td><td>Dot Scientific</td><td>AGLE-500</td><td></td></tr><tr><td>Mastercycler Gradient</td><td>Eppendorf</td><td>950000015</td><td>PCR thermocycler.</td></tr><tr><td>Centrifuge</td><td>Eppendorf</td><td>5810 R</td><td></td></tr><tr><td>Centrifuge</td><td>Eppendorf</td><td>5430R</td><td></td></tr><tr><td>Wizard SV Gel and PCR Fragment DNA Clean-Up System</td><td>Promega</td><td>A9281</td><td></td></tr><tr><td>Zero Blunt TOPO PCR Cloning Kit, with One Shot&amp;nbsp; TOP10 Chemically Competent E. coli cells</td><td>ThermoFisherScientific</td><td>K280020</td><td></td></tr><tr><td>MyPCR Preparation Station Mystaire</td><td>MidSci</td><td>MY-PCR24</td><td>Hood dedicated to PCR work.</td></tr><tr><td>Hamilton SafeAire II fume hood</td><td>ThermoFisherScientific</td><td></td><td>Fume hood.</td></tr><tr><td>Beckman Coulter Z1&amp;nbsp;Particle&amp;nbsp;Counter</td><td>Beckman Coulter</td><td>6605698</td><td>Particle counter. For counting cells before plating&amp;nbsp; for RNA extraction.</td></tr><tr><td>Applied Biosystems Sequence Scanner Software v2.0</td><td>Applied Biosystems (through ThermoFisherScientific)</td><td></td><td>Software to analyze Sanger sequencing data.</td></tr></tbody></table>

adapting 3' rapid amplification of cdna ends to map transcripts in cancer

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Maturation of eukaryotic mRNAs involves 3&#39; end formation, which involves the addition of a poly(A) tail. In order to map the 3&#39; end of a gene, the traditional method of choice is 3&#39; rapid amplification of cDNA ends (3&#39; RACE). Protocols for 3&#39; RACE require the careful design and selection of nested primers within the 3&#39; untranslated region (3&#39; UTR) of the target gene of interest. However, with a few modifications the protocol can be used to include the entire 3&#39; UTR and sequences within the open reading frame (ORF), providing a more comprehensive picture of the relationship between the ORF and the 3&#39; UTR. This is in addition to identification of the polyadenylation signal (PAS), as well as the cleavage and polyadenylation site provided by conventional 3&#39; RACE. Expanded 3&#39; RACE can detect unusual 3&#39; UTRs, including gene fusions within the 3&#39; UTR, and the sequence information can be used to predict potential miRNA binding sites as well as AU rich destabilizing elements that may affect the stability of the transcript.

Nested Forward Primer Search:
The agarose gel from Figure 1 shows two distinct PCR gel products (Lanes 1 and 2) which use the same forward primer but different reverse primers. Lane 3 has a distinct PCR product and has a distinct forward and reverse primer. The ideal primers to use for the PCR based reaction are those that give one distinct PCR product (Lane 3). The forward primer used...

The two different 3&#39; rapid amplification of cDNA ends (3&#39; RACE) protocols described here make use of two different DNA polymerases to map sequences that include a segment of the open reading frame (ORF), the stop codon, and the entire 3&#39; UTR of a transcript using RNA obtained from different cancer cell lines.

Maturation of eukaryotic mRNAs involves 3&#39; end formation, which involves the addition of a poly(A) tail. In order to map the 3&#39; end of a gene, the ...

adapting-3-rapid-amplification-cdna-ends-to-map-transcripts

Research

JoVE Journal

Genetics

Due to the transient nature of pre-mRNA, it can be difficult to isolate and study in vivo.  Here, we present a novel in vitro approach to investigate RNA-protein interactions using a synthetic oligo pool that tiles across selected regions of pre-mRNA.

A Rapid High-throughput Method for Mapping Ribonucleoproteins (RNPs) on Human pre-mRNA

We describe the preparation of barcoded DNA libraries and subsequent hybridization-based exon capture for detection of key cancer-associated mutations in clinical tumor specimens by massively parallel "next generation" sequencing. Targeted exon sequencing offers the benefits of high throughput, low cost, and deep sequence coverage, thus yielding high sensitivity for detecting low frequency mutations.

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

An integrated system for targeted next-generation sequencing of oncology specimens is described. This cross-platform system is optimized for low-quality and low-quantity tumor biopsies, accommodates low DNA inputs, includes well-characterized multi-variant controls, and features a novel variant caller that is informed by quantitative pre-analytical quality control measures.

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

We describe a targeted RNA sequencing-based method that includes preparation of indexed cDNA libraries, hybridization and capture with custom probes and data analysis to interrogate selected transcripts for gene expression, mutations, and gene fusions. Targeted RNAseq permits cost-effective, rapid evaluation of selected transcripts on a desktop sequencer.

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

This protocol describes a method for mapping pre-mRNA 3' end processing sites.

3' End Sequencing Library Preparation with A-seq2

The manuscript describes a chip-based digital PCR assay to detect a rare CDH1 transcript variant (CDH1a) in fresh-frozen normal and tumor tissues obtained from patients with gastric cancer.

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Here, we present a protocol to detect tumor somatic mutations in circulating DNA present in patient biological fluids (biofluids). Our droplet digital polymerase chain reaction (dPCR)-based method enables quantification of the tumor mutation allelic frequency (MAF), facilitating a minimally invasive complement to diagnosis and temporal monitoring of tumor response.

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

ATAC-seq is a DNA sequencing method that uses the hyperactive mutant transposase, Tn5, to map changes in chromatin accessibility mediated by transcription factors. ATAC-seq enables the discovery of the molecular mechanisms underlying phenotypic alterations in cancer cells. This protocol outlines optimization procedures for ATAC-seq in epithelial cell types, including cancer cells.

ATAC-Seq Optimization for Cancer Epigenetics Research

This protocol details a methodology for multiplex mRNA detection with protein imaging mass cytometry in formalin fixed paraffin embedded tissue sections.

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Tandem splicing events occur at sites less than 12 nucleotides apart. Quantifying ratios of such splice variants is feasible using an absolute quantitative PCR approach. This manuscript describes how splice variants of the gene STAT3, in which two splicing events results in Serine-701 inclusion/exclusion and α/β C-termini, can be quantified.

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Learn 3' RACE protocols using different DNA polymerases to map mRNA sequences from cancer cell lines. This method identifies open reading frames, stop codons, and 3' UTRs for transcript analysis.

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Explore More Videos